Atossa Therapeutics (ATOS) Other financing activities (2017 - 2024)
Atossa Therapeutics (ATOS) posted quarterly Other financing activities of $3.4 million for Q4 2024, up 84425.0% quarter-over-quarter from -$4000.0 in Q3 2024.
Atossa Therapeutics (ATOS) Other financing activities (2017 - 2024) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Other financing activities for 4 consecutive years, with $3.4 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Other financing activities changed N/A year-over-year to $3.4 million; the TTM figure through Sep 2025 stood at $3.4 million (up 1039.53% YoY), while the FY2024 annual figure was $3.7 million, changed N/A from the prior year.
- Other financing activities advanced to $3.4 million in Q4 2024 per ATOS's latest filing, from -$4000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $32.8 million in Q1 2021 and bottomed at -$4000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.37 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Sep 30, 2021 | 862,000.00 |
| Sep 30, 2021 | 862,000.00 |
| Jun 30, 2021 | 10.20 Mn |
| Jun 30, 2021 | 10.20 Mn |
| Mar 31, 2021 | 32.76 Mn |
| Mar 31, 2021 | 32.76 Mn |
| Jun 30, 2019 | 36,710.00 |
| Jun 30, 2019 | 36,710.00 |
| Mar 31, 2019 | 11.30 Mn |
| Mar 31, 2019 | 11.30 Mn |
| Dec 31, 2017 | 3,900.00 |
| Dec 31, 2017 | 3,900.00 |